Inkeun Park

8PUBLICATIONS
54CO-AUTHORS
Cancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 13, 2025
Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).

Hyehyun Jeong, Changhoon Yoo, Shinkyo Yoon

|Aug 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer.

Yeong Hak Bang, Choong-Kun Lee, Kyunghye Bang

|Feb 21, 2024
Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma.

Chulkue Pak, Shinkyo Yoon, Jae Lyun Lee

|Jan 31, 2023
Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice.

Kwonoh Park, Jin Young Kim, Inkeun Park

|Oct 16, 2020
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients.

Ja Young Seo, Jeong-Yeal Ahn, Bhumsuk Keam

|Jul 30, 2019
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03.

Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park

Pageof 2

Frequent Collaborators

3 joint publications

Jae Lyun Lee

2 joint publications

Changhoon Yoo

2 joint publications

Shinkyo Yoon

2 joint publications

Kwonoh Park